Global Type 1 Diabetes Drugs Market Insights and Forecast to 2031

Report ID: 1450869 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Type 1 Diabetes Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Type 1 Diabetes Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Insulins
        1.2.3 Others
    1.3 Market by Application
        1.3.1 Global Type 1 Diabetes Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Drugstore
        1.3.3 Hospital
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Type 1 Diabetes Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Type 1 Diabetes Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Type 1 Diabetes Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Type 1 Diabetes Drugs Sales by Region
        2.4.1 Global Type 1 Diabetes Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Type 1 Diabetes Drugs by Region (2023-2028)
    2.5 Global Type 1 Diabetes Drugs Revenue by Region
        2.5.1 Global Type 1 Diabetes Drugs Revenue by Region (2017-2022)
        2.5.2 Global Type 1 Diabetes Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Type 1 Diabetes Drugs Sales by Manufacturers
        3.1.1 Global Top Type 1 Diabetes Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Type 1 Diabetes Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Type 1 Diabetes Drugs in 2021
    3.2 Global Type 1 Diabetes Drugs Revenue by Manufacturers
        3.2.1 Global Type 1 Diabetes Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Type 1 Diabetes Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Type 1 Diabetes Drugs Revenue in 2021
    3.3 Global Type 1 Diabetes Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Type 1 Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Type 1 Diabetes Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Type 1 Diabetes Drugs Sales by Type
        4.1.1 Global Type 1 Diabetes Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Type 1 Diabetes Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Type 1 Diabetes Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Type 1 Diabetes Drugs Revenue by Type
        4.2.1 Global Type 1 Diabetes Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Type 1 Diabetes Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Type 1 Diabetes Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Type 1 Diabetes Drugs Price by Type
        4.3.1 Global Type 1 Diabetes Drugs Price by Type (2017-2022)
        4.3.2 Global Type 1 Diabetes Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Type 1 Diabetes Drugs Sales by Application
        5.1.1 Global Type 1 Diabetes Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Type 1 Diabetes Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Type 1 Diabetes Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Type 1 Diabetes Drugs Revenue by Application
        5.2.1 Global Type 1 Diabetes Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Type 1 Diabetes Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Type 1 Diabetes Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Type 1 Diabetes Drugs Price by Application
        5.3.1 Global Type 1 Diabetes Drugs Price by Application (2017-2022)
        5.3.2 Global Type 1 Diabetes Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Type 1 Diabetes Drugs Market Size by Type
        6.1.1 North America Type 1 Diabetes Drugs Sales by Type (2017-2028)
        6.1.2 North America Type 1 Diabetes Drugs Revenue by Type (2017-2028)
    6.2 North America Type 1 Diabetes Drugs Market Size by Application
        6.2.1 North America Type 1 Diabetes Drugs Sales by Application (2017-2028)
        6.2.2 North America Type 1 Diabetes Drugs Revenue by Application (2017-2028)
    6.3 North America Type 1 Diabetes Drugs Market Size by Country
        6.3.1 North America Type 1 Diabetes Drugs Sales by Country (2017-2028)
        6.3.2 North America Type 1 Diabetes Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Type 1 Diabetes Drugs Market Size by Type
        7.1.1 Europe Type 1 Diabetes Drugs Sales by Type (2017-2028)
        7.1.2 Europe Type 1 Diabetes Drugs Revenue by Type (2017-2028)
    7.2 Europe Type 1 Diabetes Drugs Market Size by Application
        7.2.1 Europe Type 1 Diabetes Drugs Sales by Application (2017-2028)
        7.2.2 Europe Type 1 Diabetes Drugs Revenue by Application (2017-2028)
    7.3 Europe Type 1 Diabetes Drugs Market Size by Country
        7.3.1 Europe Type 1 Diabetes Drugs Sales by Country (2017-2028)
        7.3.2 Europe Type 1 Diabetes Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Type 1 Diabetes Drugs Market Size by Type
        8.1.1 Asia Pacific Type 1 Diabetes Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Type 1 Diabetes Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Type 1 Diabetes Drugs Market Size by Application
        8.2.1 Asia Pacific Type 1 Diabetes Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Type 1 Diabetes Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Type 1 Diabetes Drugs Market Size by Region
        8.3.1 Asia Pacific Type 1 Diabetes Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Type 1 Diabetes Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Type 1 Diabetes Drugs Market Size by Type
        9.1.1 Latin America Type 1 Diabetes Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Type 1 Diabetes Drugs Revenue by Type (2017-2028)
    9.2 Latin America Type 1 Diabetes Drugs Market Size by Application
        9.2.1 Latin America Type 1 Diabetes Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Type 1 Diabetes Drugs Revenue by Application (2017-2028)
    9.3 Latin America Type 1 Diabetes Drugs Market Size by Country
        9.3.1 Latin America Type 1 Diabetes Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Type 1 Diabetes Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Type 1 Diabetes Drugs Market Size by Type
        10.1.1 Middle East and Africa Type 1 Diabetes Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Type 1 Diabetes Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Type 1 Diabetes Drugs Market Size by Application
        10.2.1 Middle East and Africa Type 1 Diabetes Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Type 1 Diabetes Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Type 1 Diabetes Drugs Market Size by Country
        10.3.1 Middle East and Africa Type 1 Diabetes Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Type 1 Diabetes Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Novo Nordisk
        11.1.1 Novo Nordisk Corporation Information
        11.1.2 Novo Nordisk Overview
        11.1.3 Novo Nordisk Type 1 Diabetes Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Novo Nordisk Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novo Nordisk Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Corporation Information
        11.2.2 Sanofi Overview
        11.2.3 Sanofi Type 1 Diabetes Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sanofi Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi Recent Developments
    11.3 Eli Lily
        11.3.1 Eli Lily Corporation Information
        11.3.2 Eli Lily Overview
        11.3.3 Eli Lily Type 1 Diabetes Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Eli Lily Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Eli Lily Recent Developments
    11.4 Adocia
        11.4.1 Adocia Corporation Information
        11.4.2 Adocia Overview
        11.4.3 Adocia Type 1 Diabetes Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Adocia Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Adocia Recent Developments
    11.5 Astellas Pharma
        11.5.1 Astellas Pharma Corporation Information
        11.5.2 Astellas Pharma Overview
        11.5.3 Astellas Pharma Type 1 Diabetes Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Astellas Pharma Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Astellas Pharma Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Corporation Information
        11.6.2 AstraZeneca Overview
        11.6.3 AstraZeneca Type 1 Diabetes Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 AstraZeneca Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 AstraZeneca Recent Developments
    11.7 BHV Pharma
        11.7.1 BHV Pharma Corporation Information
        11.7.2 BHV Pharma Overview
        11.7.3 BHV Pharma Type 1 Diabetes Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 BHV Pharma Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 BHV Pharma Recent Developments
    11.8 Biodel
        11.8.1 Biodel Corporation Information
        11.8.2 Biodel Overview
        11.8.3 Biodel Type 1 Diabetes Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Biodel Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Biodel Recent Developments
    11.9 Boehringer Ingelheim
        11.9.1 Boehringer Ingelheim Corporation Information
        11.9.2 Boehringer Ingelheim Overview
        11.9.3 Boehringer Ingelheim Type 1 Diabetes Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Boehringer Ingelheim Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Boehringer Ingelheim Recent Developments
    11.10 Diamyd Therapeutics AB
        11.10.1 Diamyd Therapeutics AB Corporation Information
        11.10.2 Diamyd Therapeutics AB Overview
        11.10.3 Diamyd Therapeutics AB Type 1 Diabetes Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Diamyd Therapeutics AB Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Diamyd Therapeutics AB Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Type 1 Diabetes Drugs Industry Chain Analysis
    12.2 Type 1 Diabetes Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Type 1 Diabetes Drugs Production Mode & Process
    12.4 Type 1 Diabetes Drugs Sales and Marketing
        12.4.1 Type 1 Diabetes Drugs Sales Channels
        12.4.2 Type 1 Diabetes Drugs Distributors
    12.5 Type 1 Diabetes Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Type 1 Diabetes Drugs Industry Trends
    13.2 Type 1 Diabetes Drugs Market Drivers
    13.3 Type 1 Diabetes Drugs Market Challenges
    13.4 Type 1 Diabetes Drugs Market Restraints
14 Key Findings in The Global Type 1 Diabetes Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Type 1 Diabetes Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Insulins
    Table 3. Major Manufacturers of Others
    Table 4. Global Type 1 Diabetes Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Type 1 Diabetes Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Type 1 Diabetes Drugs Sales by Region (2017-2022) & (K Units)
    Table 7. Global Type 1 Diabetes Drugs Sales Market Share by Region (2017-2022)
    Table 8. Global Type 1 Diabetes Drugs Sales by Region (2023-2028) & (K Units)
    Table 9. Global Type 1 Diabetes Drugs Sales Market Share by Region (2023-2028)
    Table 10. Global Type 1 Diabetes Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Type 1 Diabetes Drugs Revenue Market Share by Region (2017-2022)
    Table 12. Global Type 1 Diabetes Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Type 1 Diabetes Drugs Revenue Market Share by Region (2023-2028)
    Table 14. Global Type 1 Diabetes Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Type 1 Diabetes Drugs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Type 1 Diabetes Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Type 1 Diabetes Drugs Revenue Share by Manufacturers (2017-2022)
    Table 18. Type 1 Diabetes Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Type 1 Diabetes Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Type 1 Diabetes Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes Drugs as of 2021)
    Table 21. Type 1 Diabetes Drugs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Type 1 Diabetes Drugs Product Offered
    Table 23. Date of Manufacturers Enter into Type 1 Diabetes Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
    Table 26. Global Type 1 Diabetes Drugs Sales by Type (2023-2028) & (K Units)
    Table 27. Global Type 1 Diabetes Drugs Sales Share by Type (2017-2022)
    Table 28. Global Type 1 Diabetes Drugs Sales Share by Type (2023-2028)
    Table 29. Global Type 1 Diabetes Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Type 1 Diabetes Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Type 1 Diabetes Drugs Revenue Share by Type (2017-2022)
    Table 32. Global Type 1 Diabetes Drugs Revenue Share by Type (2023-2028)
    Table 33. Type 1 Diabetes Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Type 1 Diabetes Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
    Table 36. Global Type 1 Diabetes Drugs Sales by Application (2023-2028) & (K Units)
    Table 37. Global Type 1 Diabetes Drugs Sales Share by Application (2017-2022)
    Table 38. Global Type 1 Diabetes Drugs Sales Share by Application (2023-2028)
    Table 39. Global Type 1 Diabetes Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Type 1 Diabetes Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Type 1 Diabetes Drugs Revenue Share by Application (2017-2022)
    Table 42. Global Type 1 Diabetes Drugs Revenue Share by Application (2023-2028)
    Table 43. Type 1 Diabetes Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Type 1 Diabetes Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
    Table 46. North America Type 1 Diabetes Drugs Sales by Type (2023-2028) & (K Units)
    Table 47. North America Type 1 Diabetes Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Type 1 Diabetes Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
    Table 50. North America Type 1 Diabetes Drugs Sales by Application (2023-2028) & (K Units)
    Table 51. North America Type 1 Diabetes Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Type 1 Diabetes Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Type 1 Diabetes Drugs Sales by Country (2017-2022) & (K Units)
    Table 54. North America Type 1 Diabetes Drugs Sales by Country (2023-2028) & (K Units)
    Table 55. North America Type 1 Diabetes Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Type 1 Diabetes Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Type 1 Diabetes Drugs Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Type 1 Diabetes Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Type 1 Diabetes Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Type 1 Diabetes Drugs Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Type 1 Diabetes Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Type 1 Diabetes Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Type 1 Diabetes Drugs Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Type 1 Diabetes Drugs Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Type 1 Diabetes Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Type 1 Diabetes Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Type 1 Diabetes Drugs Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Type 1 Diabetes Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Type 1 Diabetes Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Type 1 Diabetes Drugs Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Type 1 Diabetes Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Type 1 Diabetes Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Type 1 Diabetes Drugs Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Type 1 Diabetes Drugs Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Type 1 Diabetes Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Type 1 Diabetes Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Type 1 Diabetes Drugs Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Type 1 Diabetes Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Type 1 Diabetes Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Type 1 Diabetes Drugs Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Type 1 Diabetes Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Type 1 Diabetes Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Type 1 Diabetes Drugs Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Type 1 Diabetes Drugs Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Type 1 Diabetes Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Type 1 Diabetes Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Type 1 Diabetes Drugs Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Type 1 Diabetes Drugs Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Type 1 Diabetes Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Type 1 Diabetes Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Type 1 Diabetes Drugs Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Type 1 Diabetes Drugs Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Type 1 Diabetes Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Type 1 Diabetes Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Type 1 Diabetes Drugs Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Type 1 Diabetes Drugs Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Type 1 Diabetes Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Type 1 Diabetes Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Novo Nordisk Corporation Information
    Table 106. Novo Nordisk Description and Major Businesses
    Table 107. Novo Nordisk Type 1 Diabetes Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Novo Nordisk Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Novo Nordisk Recent Developments
    Table 110. Sanofi Corporation Information
    Table 111. Sanofi Description and Major Businesses
    Table 112. Sanofi Type 1 Diabetes Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Sanofi Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Sanofi Recent Developments
    Table 115. Eli Lily Corporation Information
    Table 116. Eli Lily Description and Major Businesses
    Table 117. Eli Lily Type 1 Diabetes Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Eli Lily Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Eli Lily Recent Developments
    Table 120. Adocia Corporation Information
    Table 121. Adocia Description and Major Businesses
    Table 122. Adocia Type 1 Diabetes Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Adocia Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Adocia Recent Developments
    Table 125. Astellas Pharma Corporation Information
    Table 126. Astellas Pharma Description and Major Businesses
    Table 127. Astellas Pharma Type 1 Diabetes Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Astellas Pharma Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Astellas Pharma Recent Developments
    Table 130. AstraZeneca Corporation Information
    Table 131. AstraZeneca Description and Major Businesses
    Table 132. AstraZeneca Type 1 Diabetes Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. AstraZeneca Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. AstraZeneca Recent Developments
    Table 135. BHV Pharma Corporation Information
    Table 136. BHV Pharma Description and Major Businesses
    Table 137. BHV Pharma Type 1 Diabetes Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. BHV Pharma Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. BHV Pharma Recent Developments
    Table 140. Biodel Corporation Information
    Table 141. Biodel Description and Major Businesses
    Table 142. Biodel Type 1 Diabetes Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Biodel Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Biodel Recent Developments
    Table 145. Boehringer Ingelheim Corporation Information
    Table 146. Boehringer Ingelheim Description and Major Businesses
    Table 147. Boehringer Ingelheim Type 1 Diabetes Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Boehringer Ingelheim Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Boehringer Ingelheim Recent Developments
    Table 150. Diamyd Therapeutics AB Corporation Information
    Table 151. Diamyd Therapeutics AB Description and Major Businesses
    Table 152. Diamyd Therapeutics AB Type 1 Diabetes Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Diamyd Therapeutics AB Type 1 Diabetes Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Diamyd Therapeutics AB Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Type 1 Diabetes Drugs Distributors List
    Table 158. Type 1 Diabetes Drugs Customers List
    Table 159. Type 1 Diabetes Drugs Market Trends
    Table 160. Type 1 Diabetes Drugs Market Drivers
    Table 161. Type 1 Diabetes Drugs Market Challenges
    Table 162. Type 1 Diabetes Drugs Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Type 1 Diabetes Drugs Product Picture
    Figure 3. Global Type 1 Diabetes Drugs Market Share by Type in 2021 & 2028
    Figure 3. Insulins Product Picture
    Figure 4. Others Product Picture
    Figure 5. Global Type 1 Diabetes Drugs Market Share by Application in 2021 & 2028
    Figure 6. Drugstore
    Figure 7. Hospital
    Figure 8. Others
    Figure 9. Type 1 Diabetes Drugs Report Years Considered
    Figure 10. Global Type 1 Diabetes Drugs Sales 2017-2028 (K Units)
    Figure 11. Global Type 1 Diabetes Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Type 1 Diabetes Drugs Revenue 2017-2028 (US$ Million)
    Figure 13. Global Type 1 Diabetes Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Type 1 Diabetes Drugs Sales Market Share by Region (2017-2022)
    Figure 15. Global Type 1 Diabetes Drugs Sales Market Share by Region (2023-2028)
    Figure 16. North America Type 1 Diabetes Drugs Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Type 1 Diabetes Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Type 1 Diabetes Drugs Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Type 1 Diabetes Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Type 1 Diabetes Drugs Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Type 1 Diabetes Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Type 1 Diabetes Drugs Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Type 1 Diabetes Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Type 1 Diabetes Drugs Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Type 1 Diabetes Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Type 1 Diabetes Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Type 1 Diabetes Drugs in the World: Market Share by Type 1 Diabetes Drugs Revenue in 2021
    Figure 28. Global Type 1 Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Type 1 Diabetes Drugs Sales Market Share by Type (2017-2028)
    Figure 30. Global Type 1 Diabetes Drugs Revenue Market Share by Type (2017-2028)
    Figure 31. Global Type 1 Diabetes Drugs Sales Market Share by Application (2017-2028)
    Figure 32. Global Type 1 Diabetes Drugs Revenue Market Share by Application (2017-2028)
    Figure 33. North America Type 1 Diabetes Drugs Sales Market Share by Type (2017-2028)
    Figure 34. North America Type 1 Diabetes Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. North America Type 1 Diabetes Drugs Sales Market Share by Application (2017-2028)
    Figure 36. North America Type 1 Diabetes Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Type 1 Diabetes Drugs Sales Share by Country (2017-2028)
    Figure 38. North America Type 1 Diabetes Drugs Revenue Share by Country (2017-2028)
    Figure 39. U.S. Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Type 1 Diabetes Drugs Sales Market Share by Type (2017-2028)
    Figure 42. Europe Type 1 Diabetes Drugs Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Type 1 Diabetes Drugs Sales Market Share by Application (2017-2028)
    Figure 44. Europe Type 1 Diabetes Drugs Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Type 1 Diabetes Drugs Sales Share by Country (2017-2028)
    Figure 46. Europe Type 1 Diabetes Drugs Revenue Share by Country (2017-2028)
    Figure 47. Germany Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. France Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Type 1 Diabetes Drugs Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Type 1 Diabetes Drugs Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Type 1 Diabetes Drugs Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Type 1 Diabetes Drugs Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Type 1 Diabetes Drugs Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Type 1 Diabetes Drugs Revenue Share by Region (2017-2028)
    Figure 58. China Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. India Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Type 1 Diabetes Drugs Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Type 1 Diabetes Drugs Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Type 1 Diabetes Drugs Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Type 1 Diabetes Drugs Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Type 1 Diabetes Drugs Sales Share by Country (2017-2028)
    Figure 73. Latin America Type 1 Diabetes Drugs Revenue Share by Country (2017-2028)
    Figure 74. Mexico Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Type 1 Diabetes Drugs Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Type 1 Diabetes Drugs Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Type 1 Diabetes Drugs Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Type 1 Diabetes Drugs Revenue Share by Country (2017-2028)
    Figure 83. Turkey Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Type 1 Diabetes Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. Type 1 Diabetes Drugs Value Chain
    Figure 87. Type 1 Diabetes Drugs Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novo Nordisk
Sanofi
Eli Lily
Adocia
Astellas Pharma
AstraZeneca
BHV Pharma
Biodel
Boehringer Ingelheim
Diamyd Therapeutics AB
Frequently Asked Questions
Type 1 Diabetes Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Type 1 Diabetes Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Type 1 Diabetes Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dental Services

Dental Services market is segmented by players, region (country), by Type and by Application. Pla ... Read More